Affimed(AFMD)

6.39 0.04 0.6299%

今开:6.41昨收:6.35
最高:6.4173 最低:6.145
涨停价:0.0跌停价:0.0
总市值:7.65086937E8

Affimed的最新评论

Takeabreak09-17 06:34

$Affimed(AFMD)$$Adaptimmune治疗(ADAP)$ $安帝君斯(AGEN)$ 3A全部加仓!超超重!成本显著抬高!爱在深秋或者大约在冬季,提前爆发也可以!查看全文

财报披露

Affimed(AFMD)09-08 20:03

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-21-113620 Act: 34 Size: 4 MB 网页链接查看全文

Spica09-02 05:41

要是有个细胞治疗的指数基金就好了[拜托]$Affimed(AFMD)$ $Tcr2 Therapeutics(TCRR)$ $NexImmune(NEXI)$查看全文

Spica08-28 06:21

本周+25%,如果下周回调,可以上车$Affimed(AFMD)$ 2021.09.08公布中报查看全文

Takeabreak08-20 11:20

$Affimed(AFMD)$ 高点下来已腰斩,很无奈!快跌到成本了,5.6加点以示支持!查看全文

Spica07-18 19:54

回复@Takeabreak: 我问了下一位做干眼症的朋友,他是这么回复的“”Eysuvis 应该还不错,但不会成为重磅。重要的原因:lotemax一直被off label用作治疗干眼,$Kala制药(KALA)$ 只是改了一个剂型,把off label变成approved。Lotemax医生可以随便开的,会一定程度限制了Eysuvis销售“//@Takeabreak:...查看全文

山里修炼07-01 21:29

$Affimed(AFMD)$ 又傻逼了!唉查看全文

财报披露

Affimed(AFMD)07-01 19:03

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-205507 Act: 34 Size: 392 KB 网页链接查看全文

Takeabreak06-18 22:39

$安帝君斯(AGEN)$ $Kala制药(KALA)$ $Affimed(AFMD)$ BCYC, CGEN 这些都很强势!守住不动,同时间 XBI往下0.8%+。AMRS更是往上1%。吹票时间到了!![加油]查看全文

Affimed(AFMD)06-17 04:06

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-192099 Act: 34 Size: 29 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36

Affimed的公告

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-21-113620 Act: 34 Size: 4 MB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-205507 Act: 34 Size: 392 KB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-192099 Act: 34 Size: 29 KB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-167904 Act: 34 Size: 131 KB 网页链接

$Affimed(AFMD)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001072613-21-000373 Act: 34 Size: 107 KB 网页链接

$Affimed(AFMD)$ 20-F/A [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001104659-21-053202 Act: 34 Size: 77 KB 网页链接

$Affimed(AFMD)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001047469-21-000956 Act: 34 Size: 8 MB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-117084 Act: 34 Size: 170 KB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-116238 Act: 34 Size: 2 MB 网页链接

$Affimed(AFMD)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-21-050088 Act: 34 Size: 94 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21